Page last updated: 2024-08-23

1-deoxynojirimycin and mevalonic acid

1-deoxynojirimycin has been researched along with mevalonic acid in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Allen, J; Canfield, AE; Gibson, JM; Kalra, PA; Siddals, KW; Sinha, S	1

Other Studies

1 other study(ies) available for 1-deoxynojirimycin and mevalonic acid

Article	Year
Apposite insulin-like growth factor (IGF) receptor glycosylation is critical to the maintenance of vascular smooth muscle phenotype in the presence of factors promoting osteogenic differentiation and mineralization. The Journal of biological chemistry, 2011, May-13, Volume: 286, Issue:19 Topics: 1-Deoxynojirimycin; Animals; Antiviral Agents; Aorta; Cattle; Cell Differentiation; Glycerophosphates; Glycosylation; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; MAP Kinase Signaling System; Mevalonic Acid; Models, Biological; Muscle, Smooth, Vascular; Osteogenesis; Phenotype; Receptor, IGF Type 1; Receptors, Somatomedin; Tunicamycin	2011

Article

Year

Apposite insulin-like growth factor (IGF) receptor glycosylation is critical to the maintenance of vascular smooth muscle phenotype in the presence of factors promoting osteogenic differentiation and mineralization.

The Journal of biological chemistry, 2011, May-13, Volume: 286, Issue:19

Topics: 1-Deoxynojirimycin; Animals; Antiviral Agents; Aorta; Cattle; Cell Differentiation; Glycerophosphates; Glycosylation; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; MAP Kinase Signaling System; Mevalonic Acid; Models, Biological; Muscle, Smooth, Vascular; Osteogenesis; Phenotype; Receptor, IGF Type 1; Receptors, Somatomedin; Tunicamycin

2011